Sentynl expands its rare disease portfolio with potential first-in-class oral treatment for AATD-LD, a rare genetic respiratory diseaseOn option exercise, Sentynl will have the right to commercialize ...
Sentynl Therapeutics, Inc. ("Sentynl"), a U.S.-based biopharmaceutical company and wholly-owned subsidiary of Zydus Lifesciences Limited ("Zydus") and Mereo BioPharma Group plc (Nasdaq: MREO) ("Mereo" ...
Sentynl expands its rare disease portfolio with potential first-in-class oral treatment for AATD-LD, a rare genetic respiratory diseaseOn option exercise, Sentynl will have the right to commercialize ...
ADNOC Logistics and Services plc (ADNOC L&S), today reported record second quarter (Q2) and first-half (H1) 2026 results, surpassing market expectations ...
ABU DHABI - ADNOC Logistics and Services plc (ADNOC L&S), today reported record second quarter (Q2) and first-half (H1) 2026 ...
EBITDA increased 176% YoY to a record $1.1 billion, with net profit up 303% YoY to $951 million Significant outperformance is attributed to services provided in delivering energy from the UAE to the ...
Atlanta had the fourth-worst special teams in the NFL by one metric and rolled through three kickers last season. Falcons special teams coordinator Craig Aukerman — pictured speaking to the media ...
Futures indicate shares will open 0.6 per cent higher; Microsoft, Amazon, Meta to release earnings this week; traders eye local inflation print. Follow updates here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results